Cocoa Butter

1. INCI & CAS

INCI: Cocoa Butter · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Cocoa Butter is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Typical use levels (formulation guide)

• Refer to the supplier TDS to establish a suitable level in the finished formula.

Use the supplier TDS for solvent, temperature and pH.

4. Regulatory sources & global compliance

• CosIng provides reference information for Cocoa Butter; confirm the specific grade and intended use against market requirements.
• Regulation (EC) No 1223/2009 sets the requirement for the finished product's safety, including the formula in which Cocoa Butter is used, to be assessed in the final product context.
• Use current supplier documentation for the purchased Cocoa Butter grade and verify applicable destination-market filings.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; it provides no evidence that a drug or OTC monograph applies and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; consider an airless or pump format when oxidation sensitivity warrants it; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• Names Cocoa Butter as a cosmetic ingredient on this SKU

• The cosmetic listing does not substantiate drug claims, cure claims, or a certification that is absent from the product records.
• The available details for Cocoa Butter cannot verify a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

For light-oil use in lotions, balms, and cleansing oils, the reference lists caprylic/capric triglyceride.

3. Typical use levels (formulation guide)

• The guide range for lotions is 3–8% as a formulation guide.
• 20–60% is listed for cleansing oils and balms.

The oil phase is the addition point for Caprylic/Capric Triglyceride.

4. Regulatory sources & global compliance

• An entry for Caprylic/Capric Triglyceride in CosIng is not authorization for a material grade or completed cosmetic; review local requirements.
• Regulation (EC) No 1223/2009 requires an assessment addressing the safety of the finished product that contains Caprylic/Capric Triglyceride for the product in its final form.
• Establish grade-specific details for Caprylic/Capric Triglyceride from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; this reference is not approval for drug use or OTC marketing while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; review airless or pump options if oxidation presents a concern; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Caprylic/Capric Triglyceride emphasizes light-triglyceride.

• The available ingredient details provides no basis for drug claims, cure claims, or a certification that is absent from the product records.
• The available details for Caprylic/Capric Triglyceride does not support skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

Squalane is a stable hydrocarbon emollient. The referenced grade is plant-derived, with mineral oil excluded.

3. Typical use levels (formulation guide)

• The stated reference for gel-creams is 2–6% for the formula.
• The formulation record indicates 10–30% for dry oils as a formulation guide.
• Balms: 5–15%.

Add Squalane through the oil phase; no additional wax-processing shear step is called for.

4. Regulatory sources & global compliance

• CosIng information about Squalane does not itself authorize a particular grade or finished cosmetic.
• The framework in Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Squalane as a finished-product assessment.
• Review the documentation for the actual Squalane grade and the filing requirements for the target market.

5. Safety & risk assessment

The percentage is shown for cosmetic development; no drug approval or OTC-monograph status follows from this guide so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; where oxidation is a concern, evaluate airless or pump packaging; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• This formulation entry does not demonstrate therapeutic results, cure claims, or unverified certification claims.
• This cosmetic entry naming Squalane cannot verify a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.